- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Fibrodysplasia Ossificans Progressiva (FOP)
- Meeting Date: November 2024
- Public Summary Document (PSD) November 2024 PBAC Meeting - (PDF 860KB)
- Public Summary Document (PSD) November 2024 PBAC Meeting - (Word 218KB)
Palovarotene – November 2024
Palovarotene; Capsule 1 mg, Capsule 1.5 mg,Capsule 2.5 mg, Capsule 5 mg, Capsule 10 mg; Sohonos®
Last updated
30 May 2025